AstraZeneca Market Cap

AstraZeneca has a market cap or net worth of $310.93 billion as of April 16, 2026. Its market cap has increased by 36.42% in one year.

Market Cap

310.93B

Enterprise Value

335.18B

1-Year Change

36.42%

Ranking

#40

Market Cap Chart

Since November 21, 2000, AstraZeneca's market cap has increased from $126.35B to $310.93B, an increase of 146.08%. That is a compound annual growth rate of 3.61%.

Market Cap History

Date	Market Cap	% Change
Apr 15, 2026	312.06B	9.50%
Dec 31, 2025	284.98B	40.31%
Dec 31, 2024	203.11B	-2.65%
Dec 29, 2023	208.65B	-0.60%
Dec 30, 2022	209.91B	20.44%
Dec 31, 2021	174.28B	32.86%
Dec 31, 2020	131.17B	1.42%
Dec 31, 2019	129.34B	34.47%
Dec 31, 2018	96.18B	9.54%
Dec 29, 2017	87.81B	27.12%
Dec 30, 2016	69.07B	-19.47%
Dec 31, 2015	85.77B	-3.07%
Dec 31, 2014	88.48B	19.53%
Dec 31, 2013	74.02B	21.17%
Dec 31, 2012	61.09B	-6.34%
Dec 30, 2011	65.22B	-2.68%
Dec 31, 2010	67.02B	-1.37%
Dec 31, 2009	67.95B	13.67%
Dec 31, 2008	59.78B	-7.97%
Dec 31, 2007	64.96B	-23.07%
Dec 29, 2006	84.44B	6.23%
Dec 30, 2005	79.49B	29.74%
Dec 31, 2004	61.26B	-26.15%
Dec 31, 2003	82.95B	37.87%
Dec 31, 2002	60.17B	-55.10%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	809.84B
Johnson & Johnson	574.86B
AbbVie	368.65B
Merck & Co.	291.20B
Novartis AG	289.09B
Amgen	187.93B
Novo Nordisk	176.49B
Gilead Sciences	173.49B

Market Cap Rankings